HIF1A and non-small cell lung carcinoma: The regulatory mechanism of UCP2 toward the mammalian target of rapamycin (mTOR) and hypoxia‐inducible factor‐1 alpha (HIF‐1α) signaling in NSCLC was confirmed through western blotting.